Take a look back at Ilika’s 2025 progress, as the company moved from laboratory validation to manufacturing, delivering key Stereax and Goliath solid-state battery milestones...
B HODL acquires 1 Bitcoin using £70,000 loan drawdown, increasing total holdings to 158.211 BTC as part of its ongoing treasury accumulation strategy...
Ecofin U.S. Renewables Infrastructure Trust has completed the sale of its Whirlwind asset to Buho Infrastructure, including escrow and contingent payments aligned with its investment policy...
Sintana Energy Inc. has announced the admission of its common shares to the AIM market of the London Stock Exchange, with trading commencing on 23 December 2025 under the ticker SEI...
EDX Medical Group has released its interim results for the six months to 20 September 2025, reporting continued progress across its diagnostics portfolio...
Strix Group has entered into a conditional agreement to sell its Billi business to Birmingham Bidco Pty Ltd for £110 million on a cash free and debt free basis, subject to shareholder approval...
Avation plc’s Jeff Chatfield explains the rationale behind their new $300 million bond issue, upgraded credit ratings, and why a 16-year widebody lease is a milestone for the company...
ICG Enterprise Trust posted strong 15% EBITDA growth with improving margins and realisation proceeds already ahead of last year. Hardman & Co’s Mark Thomas breaks down the trust’s recent performance and outlook...
Record plc CEO Dr Jan Hendrik Witte outlines how the firm’s transition from FX-focused services into private market strategies is positioning it for scale and long-term growth...
Cizzle Biotechnology has signed a letter of intent with an NHS-linked diagnostics partner to begin UK validation of its CIZ1B lung cancer test. Executive Chairman Dr Allan Syms outlines how this complements their existing US licence and supports national early detection targets...
Soil results from Great Western Mining’s Huntoon claims in Nevada hint at something much bigger — a copper porphyry and tungsten system potentially linked over a 2.8 km trend. Executive Chairman Brian Hall explains why this could reshape the company's future...
One Health Group’s Chairman Derek Bickerstaff outlines another period of strong growth — with patient referrals, surgeons, and capacity all sharply higher...
Verge Technologies’ Jimmy Jobe reveals how AI-powered, self-healing database systems are eliminating the fragility of single-cloud dependence. With SentientDB at its core, Verge is building a future where enterprise data never goes dark...
Ilika plc CEO Graeme Purdy reveals the Goliath pilot line is now fully commissioned. With pouch cell assembly now live, the company is preparing for licensing deals and scale-up with industry partners. Watch the full interview now...
Volta Finance gives everyday investors access to outperforming private credit via CLOs — a space usually reserved for institutions. Analyst Mark Thomas breaks down the structural advantages, income strategy and manager performance behind the Hardman & Co report: “Liquid Access to Outperforming Private Credit”...
GSK plc has received US FDA approval for Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in patients aged 12 and over...
Diploma PLC has appointed Wilson Ng as Group Chief Financial Officer with immediate effect, following a formal internal and external selection process...
Bunzl plc has reaffirmed its 2025 adjusted operating profit guidance ahead of entering its closed period, with group revenue expected to grow by 2% to 3% at constant exchange rates...
Centrica has announced the sale of Spirit Energy’s remaining interests in the Cygnus gas field and other producing assets in the Southern North Sea to Serica Energy...
AstraZeneca and Daiichi Sankyo have received US FDA approval for Enhertu in combination with pertuzumab as a 1st-line treatment for adults with unresectable or metastatic HER2-positive breast cancer...
GSK has announced that Exdensur (depemokimab) has received marketing authorisation from the UK MHRA for use in certain asthma and chronic rhinosinusitis with nasal polyps patients...
WH Smith has reported preliminary results for the year ended 31 August 2025, marking the completion of its transition into a pure-play travel retailer following the sale of its High Street business and Funky Pigeon...
CMC Markets CEO Lord Peter Cruddas outlines CMC’s shift from a traditional B2C model to a technology-driven B2B powerhouse, with key partnerships including Westpac, Revolut, ASB, and Currys positioning the company for strong growth and a potential market re-rating...
PPHE Hotel Group has agreed a new £88 million refinancing facility for Park Plaza Victoria London, replacing an existing loan due to mature in early 2026...
